IMCAS 2026
( number of products: 3 )Purlés has been selected among the TOP 10 finalists chosen to present their innovative solutions at the prestigious IMCAS Industry Innovation Awards 2026 in Paris, before a Jury composed of outstanding specialists in the field of dermatology and aesthetic medicine.
IMCAS is the world's largest and most renowned congress of dermatology, cosmetology and aesthetic medicine, gathering over 18,000 doctors and experts from around the globe every year. The Industry Innovation Awards recognise solutions that deliver real clinical value, grounded in science, innovative technology and practical application in the daily work of specialists.
The Exosome Revital System presented by Purlés is an innovative, regenerative treatment system for professional skin care, encompassing in-clinic therapy and home care. The system is based on the technology of two forms of plant-derived exosomes, supporting skin regeneration and comfort after aesthetic procedures. The product formulas combine exosomes with advanced active ingredients (e.g. biomimetic peptides, probiotics and prebiotics, hyaluronic acid), supporting skin barrier restoration, long-lasting hydration and visible improvement in skin elasticity and comfort.
Home care allows to strengthen and maintain the effects of the treatment, providing long-term results; it includes: 182 ExoFusion Face Cream, 180 ExoFusion Eye Cream and the new 181 ExoFusion Intensive Serum. The products have been developed with skin in mind that requires intensive regeneration, weakened after more invasive procedures (peels, laser), with a compromised protective barrier, dry and irritated.
Purlés' presence in the final presentation of the IMCAS Industry Innovation Awards 2026 confirms its position as a creator of modern, scientifically validated, personalised solutions for professionals, ready for implementation in everyday practice.